In contrast, at least focal HMB-45 positivity was demonstrated in 43 of 79 (54%) typical (non-epithelioid) smooth muscle tumors of the uterus in 2 combined series [60,61]. This evidence concerns the gene PMEL and smooth muscle tumor.